The ESH 4th Translational Research Conference on Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy. Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training.

 

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.

 

This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!

Why the meeting will be valuable for participants?

– It fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide

– It provides opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training

– A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.

 

Scientific Topics:

– Spectrum of CLL – one disease or more

– Richter transformation

– Drivers of disease progression – from genetics, epigenetics, and proteomics (complexity of the evolution)

– The microenvironment of CLL

– Time limited therapies: which combination? which duration? which markers to stop therapy?

– BTK inhibition or degradation?

– The new challenge: resistance to one or two inhibitor classes? – Double refractory CLL

– Future therapies, new compounds

– Directions and strategies to use the best agents in the optimal way: sequencing, combinations, costs of therapy, availability

 

The programme will include:

– Plenary Sessions

– Brief Oral Communications

– Debates

– Panel Discussions

– Poster Walks

– Meet the Expert Sessions

– Brief Oral Communications

– Ample time for in-depth discussion

 

The meeting will be of interest to:

• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)

• Junior scientists and clinicians (MD, PhD)

• PhD candidates and clinical residents still in-training

 

Learning Objectives:

Upon completion of this CME activity, participants should:

– Understand recent advances in elucidating the pathogenesis of CLL

– Describe recent data on therapeutic regimens for CLL

– Understand emerging data on mechanisms of resistance to targeted agents in CLL

– Understand the debate about how best to optimize CLL therapy in the future

Register here

Direct email queries to: [email protected]

External Events

Nov 26
24
25
26
Jan 27
18
19
28
Feb 27
1
24
25
26
November 24th 2026
Current Thinking in Haematological Malignancies...
The programme for this meeting has been designed to combine high calibre lectures and interactive discussions to prov...
Details
November 25th 2026
RCPath & SHOT Advances in Transfusion Symposium...
This popular biennial symposium brings together expert speakers in transfusion medicine and science. It is suitable f...
Details
November 26th 2026
Glasgow Surgical Forum 2026
Advances in Surgical Oncology: Evidence, Practice and Outcomes'. An essential update for the general and specialist s...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch (1)
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
January 18th 2027
Multiple Myeloma Preceptorship 2027
Join us for our face-to-face preceptorship programme. You will receive the latest updates regarding Multiple Myeloma...
Details
January 19th 2027
Post ASH Significant Highlights (6)
An annual January event , where highlights will be presented from the ASH meeting. The aim of this 2 day event is to...
Details
January 28th 2027
Innovations in Transplant and Cellular Therapy
The programme for the Innovations in Transplant and Cellular Therapy Day will focus on novel therapies, transplant co...
Details
February 1st 2027
CLL and Lymphomas in Practice Preceptorship 2027
Join us to explore the latest approaches to managing chronic lymphocytic leukaemia (CLL), follicular lymphoma, margin...
Details
February 24th 2027
UCLH: Challenges in MPN - Medical
Join us for a clinically focused and highly interactive study day dedicated to the management of complex MPN (myelopr...
Details
February 25th 2027
UCLH: Challenges in MPN - Nursing
This study day has been designed specifically for Clinical Nurse Specialists working with patients living with myelop...
Details
February 26th 2027
OB Shock: Hemorrhage, Hemodynamics & Hemostasis...
This multidisciplinary workshop advances clinical decision-making in complex obstetric hemorrhage through applied coa...
Details